A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa Versus Placebo in Patients With Persistent Anemia as a Result of Cancer Treatment With Cisplatin, a Platinum-Containing Chemotherapy Drug
This study has been completed.
Study NCT00269997.
Last updated on October 19, 2007.
Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study: